DPThe decentralised procedure is a process for authorising medicines in more than one European Union member state at the same time.
Decentralised procedureThe decentralised procedure is a process for authorising medicines in more than one European Union member state at the same time.
DegradantsChemical products formed from the breakdown of a medicine due to for example light, temperature, water, reaction with non-active substances, or container and closure systems, etc.
Delivery deviceA device used for the delivery of a medicine or therapeutic agent via a specific route of administration (e.g. inhaler, dermal patch or infusion pump).
Delivery systemMedicine delivery systems encompass four main related aspects: Routes of delivery (ways in which the medications can be taken, such as orally, by injection, by inhalation, etc.). Delivery vehicles (dosage forms such as pills or slow-release granules). Chemical/biological properties of the(...)
DSURThe Development Safety Update Report is an annual review of safety information during clinical trials of a medicine under investigation – whether or not it is marketed. The main objectives of a Development Safety Update Report is to:
Summarise the current understanding and management of(...)
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
